141 related articles for article (PubMed ID: 21967990)
1. Impact of factor VIII and von Willebrand factor plasma levels on cerebral venous and sinus thrombosis: are they independent risk factors?
Shahsavarzadeh T; Javanmard SH; Saadatnia M
Eur Neurol; 2011; 66(4):243-6. PubMed ID: 21967990
[TBL] [Abstract][Full Text] [Related]
2. Repeated infusions of VWF/FVIII concentrate: impact of VWF:FVIII ratio on FVIII trough and peak levels in a rabbit model.
Raquet E; Stockschläder M; Dickneite G
Haemophilia; 2011 Sep; 17(5):808-14. PubMed ID: 21726357
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality.
Catto AJ; Carter AM; Barrett JH; Bamford J; Rice PJ; Grant PJ
Thromb Haemost; 1997 Jun; 77(6):1104-8. PubMed ID: 9241740
[TBL] [Abstract][Full Text] [Related]
4. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
[TBL] [Abstract][Full Text] [Related]
5. Von Willebrand factor drives the association between elevated factor VIII and poor outcomes in patients with ischemic stroke.
Samai A; Monlezun D; Shaban A; George A; Dowell L; Kruse-Jarres R; Schluter L; El Khoury R; Martin-Schild S
Stroke; 2014 Sep; 45(9):2789-91. PubMed ID: 25028444
[TBL] [Abstract][Full Text] [Related]
6. Changes in the levels of factor VIII and von Willebrand factor in the puerperium.
Huq FY; Kulkarni A; Agbim EC; Riddell A; Tuddenham E; Kadir RA
Haemophilia; 2012 Mar; 18(2):241-5. PubMed ID: 21951573
[TBL] [Abstract][Full Text] [Related]
7. Role of hemostatic factors on the risk of venous thrombosis in people with impaired kidney function.
Ocak G; Vossen CY; Lijfering WM; Verduijn M; Dekker FW; Rosendaal FR; Cannegieter SC
Circulation; 2014 Feb; 129(6):683-91. PubMed ID: 24211824
[TBL] [Abstract][Full Text] [Related]
8. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
[TBL] [Abstract][Full Text] [Related]
9. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
[TBL] [Abstract][Full Text] [Related]
10. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
[TBL] [Abstract][Full Text] [Related]
11. Intranasal DDAVP induced increases in plasma von Willebrand factor alter the pharmacokinetics of high-purity factor VIII concentrates in severe haemophilia A patients.
Deitcher SR; Tuller J; Johnson JA
Haemophilia; 1999 Mar; 5(2):88-95. PubMed ID: 10215955
[TBL] [Abstract][Full Text] [Related]
12. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
Morelli VM; de Visser MC; van Tilburg NH; Vos HL; Eikenboom JC; Rosendaal FR; Bertina RM
Thromb Haemost; 2007 Apr; 97(4):534-41. PubMed ID: 17393014
[TBL] [Abstract][Full Text] [Related]
13. Procoagulant factors and the risk of myocardial infarction in young women.
Tanis B; Algra A; van der Graaf Y; Helmerhorst F; Rosendaal F
Eur J Haematol; 2006 Jul; 77(1):67-73. PubMed ID: 16608503
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand factor and factor VIII in renal transplant recipients under immunosuppression with cyclosporine and steroids. Sequential measurements over 4 months in 17 patients.
Huser B; Lämmle B; Landmann J; Tran TH; Oberholzer M; Marbet GA; Thiel G; Mihatsch MJ; Duckert F
Clin Nephrol; 1990 Nov; 34(5):214-22. PubMed ID: 2125251
[TBL] [Abstract][Full Text] [Related]
15. Cerebral venous thrombosis and plasma concentrations of factor VIII and von Willebrand factor: a case control study.
Bugnicourt JM; Roussel B; Tramier B; Lamy C; Godefroy O
J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):699-701. PubMed ID: 17189302
[TBL] [Abstract][Full Text] [Related]
16. A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic.
Kawasaki T; Kaida T; Arnout J; Vermylen J; Hoylaerts MF
Thromb Haemost; 1999 Feb; 81(2):306-11. PubMed ID: 10064011
[TBL] [Abstract][Full Text] [Related]
17. High factor VIII (FVIII) levels in venous thromboembolism: role of unbound FVIII.
Schambeck CM; Grossmann R; Zonnur S; Berger M; Teuchert K; Spahn A; Walter U
Thromb Haemost; 2004 Jul; 92(1):42-6. PubMed ID: 15213843
[TBL] [Abstract][Full Text] [Related]
18. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor.
Rietveld IM; Lijfering WM; le Cessie S; Bos MHA; Rosendaal FR; Reitsma PH; Cannegieter SC
J Thromb Haemost; 2019 Jan; 17(1):99-109. PubMed ID: 30471183
[TBL] [Abstract][Full Text] [Related]
19. Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension.
Wong CL; Szydlo R; Gibbs S; Laffan M
Blood Coagul Fibrinolysis; 2010 Apr; 21(3):201-6. PubMed ID: 20182352
[TBL] [Abstract][Full Text] [Related]
20. Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism.
Shovlin CL; Sulaiman NL; Govani FS; Jackson JE; Begbie ME
Thromb Haemost; 2007 Nov; 98(5):1031-9. PubMed ID: 18000608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
